{{ $ActivityName }}
< 5 years
5-10 years
11-20 years
>20 years
General Surgery
Gastrointestinal Surgery
Orthopedic Surgery
Oncosurgery
Other
Private hospital/clinic
Government hospital/medical college
Multi-specialty hospital
Rarely (<10% of cases)
Occasionally (10-30%)
Frequently (31-50%)
Very frequently (>50%)
<10%
10-30%
31-50%
>50%
Gut microbiota restoration
Prevention of infections
Management of antibiotic-associated diarrhoea
Immune modulation
Gastrointestinal surgery
General surgery
Orthopedic surgery
All of the above
Others
Significant influence via immunomodulation and barrier function enhancement
Limited influence, primarily confined to digestive processes
Negligible influence on surgical outcome
I am not sure
Yes, for all patients
Yes, for high-risk patients
No, only in specific cases
Probiotics should not be used
Always, with all eligible patients
Often, in most cases
Sometimes, based on specific patient criteria
Rarely, only in select cases
Never, probiotics are not part of my pre-surgical counseling
Yes, routinely
Occasionally
Rarely
Never
Not available in my setup
Very important
Moderately important
Not very important
Not important at all
Symptomatic relief and clinical outcomes
Laboratory parameters
Reduction in complications (infections, diarrhoea, etc.)
I do not evaluate probiotic effectiveness
Occasionally (case-dependent)
Frequently (for high-risk patients)
Routinely for all surgical patients
With antibiotics
On an empty stomach
With meals
Before bedtime
Anytime, regardless of food
1-2 days
3-7 days
1-2 weeks
More than 2 weeks
I do not typically recommend pre-operative probiotic administration
Immediately post-operatively
24-48 hours post-operatively
1-week post-operatively
I do not prescribe probiotics post-surgically
2-4 weeks
Until discharge from hospital
Until the complete resolution of post-surgical symptoms
Long-term (more than 4 weeks)
Duration is patient specific, hence variable
I do not typically recommend post-operative probiotic administration
Single-strain probiotics
Multi-strain probiotics
Synbiotics (probiotics + prebiotics)
Lactobacillus species
Bifidobacterium species
Lactococcus lactis
Streptococcus thermophilus
Enterococcus species
Other single strain probiotic or a combination of several strains
I do not prescribe specific probiotic strains
I am not familiar with specific probiotic strains
Strain specificity is negligible; efficacy primarily depends on dosage
Strain specificity is a critical determinant of therapeutic efficacy
High dosage is the sole determinant of probiotic effectiveness
Both strain specificity and dosage are equally significant
Yes, always, I ensure the CFU count aligns with clinical needs
Sometimes, I consider it depending on the patient's condition
Rarely, I rely more on the brand, strain, or formulation
Never, I do not consider CFU count in my decision-making
Capsules
Powders
Liquids
Chewable tablets
I do not use probiotic supplements
Ease of administration
Clinical effectiveness
Onset of therapeutic action
Brand reputation and reliability
Patient compliance and tolerability
Cost-effectiveness
Yes, a significant reduction in infections
Yes, a moderate reduction in infections
No noticeable difference in infection rates
They significantly reduce both incidence and severity
They help in moderate reduction, primarily in incidence
They have minimal to no impact on either incidence or severity
They have a potential to exacerbate complications
Significantly
Moderately
Marginally
It is patient- and case-specific
Not at all
Strongly agree
Agree
Disagree
Yes, significantly
Yes, but only slightly
Yes, frequently
Yes, occasionally
Yes
No
Evidence-based clinical practice guidelines
Medical literature/ Peer-reviewed scientific publications
Expert consensus and discussions with specialists
Conferences and workshops
Industry-sponsored research and educational materials/ Pharmaceutical representatives
Personal clinical observations/ clinical practice